Research evaluating NHDC, Miraculin, and Mogrosides as zero-calorie natural sweeteners for beverages. These FDA-approved compounds offer high sweetness intensity, blood glucose neutrality, and potential benefits for diabetes and obesity management in beverage formulations.
This research investigates three natural, non-nutritive sweeteners—Neohesperidin dihydrochalcone (NHDC), Miraculin, and Mogrosides—as superior sugar replacements for beverage applications. The project addresses growing consumer demand for low-calorie and zero-calorie beverage options that maintain the palatability of sugar without caloric content or toxicological concerns. All three compounds are FDA-approved and offer distinct functional advantages, including dramatically higher sweetness intensity than sucrose, minimal impact on blood glucose levels, and potential anti-diabetic and anti-obesity properties. The research aims to characterize these sweeteners' physicochemical properties, stability, and sensory performance to enable their practical use in beverage formulations.
Sweetener profiles under investigation:
Validation activities planned:
This research is currently at an early-to-mid stage of development. The proposed validation procedures include comprehensive physicochemical characterization, stability testing, sensory evaluations, and long-term shelf-life studies. Future work will assess in vitro digestibility, bioavailability, and antioxidant properties across extended storage periods. The research represents foundational analysis required before commercial beverage application, with planned optimization steps to address undesirable characteristics and ensure formulation compatibility.
A specialized public university in Wrocław focused on environmental and life sciences, recognized for applied, industry‑engaged research. Companies collaborate through on‑site laboratories, field research sites, controlled‑environment facilities, and veterinary clinical services that enable testing, validation, and demonstration with academic experts. Its location within Wrocław’s innovation ecosystem and the broader Lower Silesia economy supports contract studies, field trials, and workforce pipelines with regional producers, utilities, and technology firms. Research is supported by competitive European and national programs, including EU framework funding and Poland’s principal science and innovation agencies. A central technology transfer office manages IP, licensing, and startup formation while providing a single front door for industry.